Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global Nonspecific Endonuclease Market Research Report 2025

Global Nonspecific Endonuclease Market Research Report 2025

Industry: Medical Devices & Consumables

Published Date: 2025-03-10

Pages: 74 Pages

Report ld: 4612298

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Nonspecific Endonuclease Market Size(US$)

CAGR 2025-2031

8.5%

Market Size,2031

USD 650

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 398 million

Market Forecast in 2031(Value)

US$ 650 million

CAGR

8.5%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Nonspecific Endonuclease was valued at US$ 370 million in the year 2024 and is projected to reach a revised size of US$ 650 million by 2031, growing at a CAGR of 8.5% during the forecast period.

Nonspecific Endonuclease, a genetically engineered enzyme from Serratia Marcescen. It can degrade all forms of DNA and RNA, including single-stranded, double-stranded, linear, circular, native and denatured nucleic acids, digesting them into 5-monophosphate oligonucleotides of 3-8 bases in length, and has no base recognition specificity.

North American market for Nonspecific Endonuclease is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Nonspecific Endonuclease is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Nonspecific Endonuclease in Biological Laboratory is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Nonspecific Endonuclease include Thermo Fisher Scientific Inc., RayBiotech, Inc., TransGen Biotech, AbMole BioScience, Yisheng Biotechnology (Shanghai) Co., Ltd., GenScript, Shanghai Biyuntian Biotechnology Co., Ltd., KACTUS, Shanghai Zhudian Biotechnology Co., Ltd., ACROBiosystems Group, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Nonspecific Endonuclease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nonspecific Endonuclease.

The Nonspecific Endonuclease market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nonspecific Endonuclease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nonspecific Endonuclease companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

MARKET SEGMENTATION

By Company

Thermo Fisher Scientific Inc.
RayBiotech, Inc.
TransGen Biotech
AbMole BioScience
Yisheng Biotechnology (Shanghai) Co., Ltd.
GenScript
Shanghai Biyuntian Biotechnology Co., Ltd.
KACTUS
Shanghai Zhudian Biotechnology Co., Ltd.
ACROBiosystems Group

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

5kU
25kU
50kU
100kU
＞100kU

Segment by Application

Biological Laboratory
University Research Room
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nonspecific Endonuclease company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Nonspecific Endonuclease Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 5kU

1.2.3 25kU

1.2.4 50kU

1.2.5 100kU

1.2.6 ＞100kU

1.3 Market by Application

1.3.1 Global Nonspecific Endonuclease Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Biological Laboratory

1.3.3 University Research Room

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Nonspecific Endonuclease Market Perspective (2020-2031)

2.2 Global Nonspecific Endonuclease Growth Trends by Region

2.2.1 Global Nonspecific Endonuclease Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Nonspecific Endonuclease Historic Market Size by Region (2020-2025)

2.2.3 Nonspecific Endonuclease Forecasted Market Size by Region (2026-2031)

2.3 Nonspecific Endonuclease Market Dynamics

2.3.1 Nonspecific Endonuclease Industry Trends

2.3.2 Nonspecific Endonuclease Market Drivers

2.3.3 Nonspecific Endonuclease Market Challenges

2.3.4 Nonspecific Endonuclease Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Nonspecific Endonuclease Players by Revenue

3.1.1 Global Top Nonspecific Endonuclease Players by Revenue (2020-2025)

3.1.2 Global Nonspecific Endonuclease Revenue Market Share by Players (2020-2025)

3.2 Global Top Nonspecific Endonuclease Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Nonspecific Endonuclease Revenue

3.4 Global Nonspecific Endonuclease Market Concentration Ratio

3.4.1 Global Nonspecific Endonuclease Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Nonspecific Endonuclease Revenue in 2024

3.5 Global Key Players of Nonspecific Endonuclease Head office and Area Served

3.6 Global Key Players of Nonspecific Endonuclease, Product and Application

3.7 Global Key Players of Nonspecific Endonuclease, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Nonspecific Endonuclease Breakdown Data by Type

4.1 Global Nonspecific Endonuclease Historic Market Size by Type (2020-2025)

4.2 Global Nonspecific Endonuclease Forecasted Market Size by Type (2026-2031)

5 Nonspecific Endonuclease Breakdown Data by Application

5.1 Global Nonspecific Endonuclease Historic Market Size by Application (2020-2025)

5.2 Global Nonspecific Endonuclease Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Nonspecific Endonuclease Market Size (2020-2031)

6.2 North America Nonspecific Endonuclease Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Nonspecific Endonuclease Market Size by Country (2020-2025)

6.4 North America Nonspecific Endonuclease Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Nonspecific Endonuclease Market Size (2020-2031)

7.2 Europe Nonspecific Endonuclease Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Nonspecific Endonuclease Market Size by Country (2020-2025)

7.4 Europe Nonspecific Endonuclease Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Nonspecific Endonuclease Market Size (2020-2031)

8.2 Asia-Pacific Nonspecific Endonuclease Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Nonspecific Endonuclease Market Size by Region (2020-2025)

8.4 Asia-Pacific Nonspecific Endonuclease Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Nonspecific Endonuclease Market Size (2020-2031)

9.2 Latin America Nonspecific Endonuclease Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Nonspecific Endonuclease Market Size by Country (2020-2025)

9.4 Latin America Nonspecific Endonuclease Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Nonspecific Endonuclease Market Size (2020-2031)

10.2 Middle East & Africa Nonspecific Endonuclease Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Nonspecific Endonuclease Market Size by Country (2020-2025)

10.4 Middle East & Africa Nonspecific Endonuclease Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Thermo Fisher Scientific Inc.

11.1.1 Thermo Fisher Scientific Inc. Company Details

11.1.2 Thermo Fisher Scientific Inc. Business Overview

11.1.3 Thermo Fisher Scientific Inc. Nonspecific Endonuclease Introduction

11.1.4 Thermo Fisher Scientific Inc. Revenue in Nonspecific Endonuclease Business (2020-2025)

11.1.5 Thermo Fisher Scientific Inc. Recent Development

11.2 RayBiotech, Inc.

11.2.1 RayBiotech, Inc. Company Details

11.2.2 RayBiotech, Inc. Business Overview

11.2.3 RayBiotech, Inc. Nonspecific Endonuclease Introduction

11.2.4 RayBiotech, Inc. Revenue in Nonspecific Endonuclease Business (2020-2025)

11.2.5 RayBiotech, Inc. Recent Development

11.3 TransGen Biotech

11.3.1 TransGen Biotech Company Details

11.3.2 TransGen Biotech Business Overview

11.3.3 TransGen Biotech Nonspecific Endonuclease Introduction

11.3.4 TransGen Biotech Revenue in Nonspecific Endonuclease Business (2020-2025)

11.3.5 TransGen Biotech Recent Development

11.4 AbMole BioScience

11.4.1 AbMole BioScience Company Details

11.4.2 AbMole BioScience Business Overview

11.4.3 AbMole BioScience Nonspecific Endonuclease Introduction

11.4.4 AbMole BioScience Revenue in Nonspecific Endonuclease Business (2020-2025)

11.4.5 AbMole BioScience Recent Development

11.5 Yisheng Biotechnology (Shanghai) Co., Ltd.

11.5.1 Yisheng Biotechnology (Shanghai) Co., Ltd. Company Details

11.5.2 Yisheng Biotechnology (Shanghai) Co., Ltd. Business Overview

11.5.3 Yisheng Biotechnology (Shanghai) Co., Ltd. Nonspecific Endonuclease Introduction

11.5.4 Yisheng Biotechnology (Shanghai) Co., Ltd. Revenue in Nonspecific Endonuclease Business (2020-2025)

11.5.5 Yisheng Biotechnology (Shanghai) Co., Ltd. Recent Development

11.6 GenScript

11.6.1 GenScript Company Details

11.6.2 GenScript Business Overview

11.6.3 GenScript Nonspecific Endonuclease Introduction

11.6.4 GenScript Revenue in Nonspecific Endonuclease Business (2020-2025)

11.6.5 GenScript Recent Development

11.7 Shanghai Biyuntian Biotechnology Co., Ltd.

11.7.1 Shanghai Biyuntian Biotechnology Co., Ltd. Company Details

11.7.2 Shanghai Biyuntian Biotechnology Co., Ltd. Business Overview

11.7.3 Shanghai Biyuntian Biotechnology Co., Ltd. Nonspecific Endonuclease Introduction

11.7.4 Shanghai Biyuntian Biotechnology Co., Ltd. Revenue in Nonspecific Endonuclease Business (2020-2025)

11.7.5 Shanghai Biyuntian Biotechnology Co., Ltd. Recent Development

11.8 KACTUS

11.8.1 KACTUS Company Details

11.8.2 KACTUS Business Overview

11.8.3 KACTUS Nonspecific Endonuclease Introduction

11.8.4 KACTUS Revenue in Nonspecific Endonuclease Business (2020-2025)

11.8.5 KACTUS Recent Development

11.9 Shanghai Zhudian Biotechnology Co., Ltd.

11.9.1 Shanghai Zhudian Biotechnology Co., Ltd. Company Details

11.9.2 Shanghai Zhudian Biotechnology Co., Ltd. Business Overview

11.9.3 Shanghai Zhudian Biotechnology Co., Ltd. Nonspecific Endonuclease Introduction

11.9.4 Shanghai Zhudian Biotechnology Co., Ltd. Revenue in Nonspecific Endonuclease Business (2020-2025)

11.9.5 Shanghai Zhudian Biotechnology Co., Ltd. Recent Development

11.10 ACROBiosystems Group

11.10.1 ACROBiosystems Group Company Details

11.10.2 ACROBiosystems Group Business Overview

11.10.3 ACROBiosystems Group Nonspecific Endonuclease Introduction

11.10.4 ACROBiosystems Group Revenue in Nonspecific Endonuclease Business (2020-2025)

11.10.5 ACROBiosystems Group Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Nonspecific Endonuclease Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of 5kU

Table 3. Key Players of 25kU

Table 4. Key Players of 50kU

Table 5. Key Players of 100kU

Table 6. Key Players of ＞100kU

Table 7. Global Nonspecific Endonuclease Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Nonspecific Endonuclease Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Nonspecific Endonuclease Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Nonspecific Endonuclease Market Share by Region (2020-2025)

Table 11. Global Nonspecific Endonuclease Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Nonspecific Endonuclease Market Share by Region (2026-2031)

Table 13. Nonspecific Endonuclease Market Trends

Table 14. Nonspecific Endonuclease Market Drivers

Table 15. Nonspecific Endonuclease Market Challenges

Table 16. Nonspecific Endonuclease Market Restraints

Table 17. Global Nonspecific Endonuclease Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Nonspecific Endonuclease Market Share by Players (2020-2025)

Table 19. Global Top Nonspecific Endonuclease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nonspecific Endonuclease as of 2024)

Table 20. Ranking of Global Top Nonspecific Endonuclease Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Nonspecific Endonuclease Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Nonspecific Endonuclease, Headquarters and Area Served

Table 23. Global Key Players of Nonspecific Endonuclease, Product and Application

Table 24. Global Key Players of Nonspecific Endonuclease, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Nonspecific Endonuclease Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Nonspecific Endonuclease Revenue Market Share by Type (2020-2025)

Table 28. Global Nonspecific Endonuclease Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Nonspecific Endonuclease Revenue Market Share by Type (2026-2031)

Table 30. Global Nonspecific Endonuclease Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Nonspecific Endonuclease Revenue Market Share by Application (2020-2025)

Table 32. Global Nonspecific Endonuclease Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Nonspecific Endonuclease Revenue Market Share by Application (2026-2031)

Table 34. North America Nonspecific Endonuclease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Nonspecific Endonuclease Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Nonspecific Endonuclease Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Nonspecific Endonuclease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Nonspecific Endonuclease Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Nonspecific Endonuclease Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Nonspecific Endonuclease Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Nonspecific Endonuclease Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Nonspecific Endonuclease Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Nonspecific Endonuclease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Nonspecific Endonuclease Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Nonspecific Endonuclease Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Nonspecific Endonuclease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Nonspecific Endonuclease Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Nonspecific Endonuclease Market Size by Country (2026-2031) & (US$ Million)

Table 49. Thermo Fisher Scientific Inc. Company Details

Table 50. Thermo Fisher Scientific Inc. Business Overview

Table 51. Thermo Fisher Scientific Inc. Nonspecific Endonuclease Product

Table 52. Thermo Fisher Scientific Inc. Revenue in Nonspecific Endonuclease Business (2020-2025) & (US$ Million)

Table 53. Thermo Fisher Scientific Inc. Recent Development

Table 54. RayBiotech, Inc. Company Details

Table 55. RayBiotech, Inc. Business Overview

Table 56. RayBiotech, Inc. Nonspecific Endonuclease Product

Table 57. RayBiotech, Inc. Revenue in Nonspecific Endonuclease Business (2020-2025) & (US$ Million)

Table 58. RayBiotech, Inc. Recent Development

Table 59. TransGen Biotech Company Details

Table 60. TransGen Biotech Business Overview

Table 61. TransGen Biotech Nonspecific Endonuclease Product

Table 62. TransGen Biotech Revenue in Nonspecific Endonuclease Business (2020-2025) & (US$ Million)

Table 63. TransGen Biotech Recent Development

Table 64. AbMole BioScience Company Details

Table 65. AbMole BioScience Business Overview

Table 66. AbMole BioScience Nonspecific Endonuclease Product

Table 67. AbMole BioScience Revenue in Nonspecific Endonuclease Business (2020-2025) & (US$ Million)

Table 68. AbMole BioScience Recent Development

Table 69. Yisheng Biotechnology (Shanghai) Co., Ltd. Company Details

Table 70. Yisheng Biotechnology (Shanghai) Co., Ltd. Business Overview

Table 71. Yisheng Biotechnology (Shanghai) Co., Ltd. Nonspecific Endonuclease Product

Table 72. Yisheng Biotechnology (Shanghai) Co., Ltd. Revenue in Nonspecific Endonuclease Business (2020-2025) & (US$ Million)

Table 73. Yisheng Biotechnology (Shanghai) Co., Ltd. Recent Development

Table 74. GenScript Company Details

Table 75. GenScript Business Overview

Table 76. GenScript Nonspecific Endonuclease Product

Table 77. GenScript Revenue in Nonspecific Endonuclease Business (2020-2025) & (US$ Million)

Table 78. GenScript Recent Development

Table 79. Shanghai Biyuntian Biotechnology Co., Ltd. Company Details

Table 80. Shanghai Biyuntian Biotechnology Co., Ltd. Business Overview

Table 81. Shanghai Biyuntian Biotechnology Co., Ltd. Nonspecific Endonuclease Product

Table 82. Shanghai Biyuntian Biotechnology Co., Ltd. Revenue in Nonspecific Endonuclease Business (2020-2025) & (US$ Million)

Table 83. Shanghai Biyuntian Biotechnology Co., Ltd. Recent Development

Table 84. KACTUS Company Details

Table 85. KACTUS Business Overview

Table 86. KACTUS Nonspecific Endonuclease Product

Table 87. KACTUS Revenue in Nonspecific Endonuclease Business (2020-2025) & (US$ Million)

Table 88. KACTUS Recent Development

Table 89. Shanghai Zhudian Biotechnology Co., Ltd. Company Details

Table 90. Shanghai Zhudian Biotechnology Co., Ltd. Business Overview

Table 91. Shanghai Zhudian Biotechnology Co., Ltd. Nonspecific Endonuclease Product

Table 92. Shanghai Zhudian Biotechnology Co., Ltd. Revenue in Nonspecific Endonuclease Business (2020-2025) & (US$ Million)

Table 93. Shanghai Zhudian Biotechnology Co., Ltd. Recent Development

Table 94. ACROBiosystems Group Company Details

Table 95. ACROBiosystems Group Business Overview

Table 96. ACROBiosystems Group Nonspecific Endonuclease Product

Table 97. ACROBiosystems Group Revenue in Nonspecific Endonuclease Business (2020-2025) & (US$ Million)

Table 98. ACROBiosystems Group Recent Development

Table 99. Research Programs/Design for This Report

Table 100. Key Data Information from Secondary Sources

Table 101. Key Data Information from Primary Sources

Table 102. Authors List of This Report

List of Figures

Figure 1. Nonspecific Endonuclease Picture

Figure 2. Global Nonspecific Endonuclease Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Nonspecific Endonuclease Market Share by Type: 2024 VS 2031

Figure 4. 5kU Features

Figure 5. 25kU Features

Figure 6. 50kU Features

Figure 7. 100kU Features

Figure 8. ＞100kU Features

Figure 9. Global Nonspecific Endonuclease Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Nonspecific Endonuclease Market Share by Application: 2024 VS 2031

Figure 11. Biological Laboratory Case Studies

Figure 12. University Research Room Case Studies

Figure 13. Others Case Studies

Figure 14. Nonspecific Endonuclease Report Years Considered

Figure 15. Global Nonspecific Endonuclease Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Nonspecific Endonuclease Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Nonspecific Endonuclease Market Share by Region: 2024 VS 2031

Figure 18. Global Nonspecific Endonuclease Market Share by Players in 2024

Figure 19. Global Nonspecific Endonuclease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 20. The Top 10 and 5 Players Market Share by Nonspecific Endonuclease Revenue in 2024

Figure 21. North America Nonspecific Endonuclease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Nonspecific Endonuclease Market Share by Country (2020-2031)

Figure 23. United States Nonspecific Endonuclease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Nonspecific Endonuclease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Nonspecific Endonuclease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Nonspecific Endonuclease Market Share by Country (2020-2031)

Figure 27. Germany Nonspecific Endonuclease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Nonspecific Endonuclease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Nonspecific Endonuclease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Nonspecific Endonuclease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Nonspecific Endonuclease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Nonspecific Endonuclease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Nonspecific Endonuclease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Nonspecific Endonuclease Market Share by Region (2020-2031)

Figure 35. China Nonspecific Endonuclease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Nonspecific Endonuclease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Nonspecific Endonuclease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Nonspecific Endonuclease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Nonspecific Endonuclease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Nonspecific Endonuclease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Nonspecific Endonuclease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Nonspecific Endonuclease Market Share by Country (2020-2031)

Figure 43. Mexico Nonspecific Endonuclease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Nonspecific Endonuclease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Nonspecific Endonuclease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Nonspecific Endonuclease Market Share by Country (2020-2031)

Figure 47. Turkey Nonspecific Endonuclease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Nonspecific Endonuclease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Nonspecific Endonuclease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Thermo Fisher Scientific Inc. Revenue Growth Rate in Nonspecific Endonuclease Business (2020-2025)

Figure 51. RayBiotech, Inc. Revenue Growth Rate in Nonspecific Endonuclease Business (2020-2025)

Figure 52. TransGen Biotech Revenue Growth Rate in Nonspecific Endonuclease Business (2020-2025)

Figure 53. AbMole BioScience Revenue Growth Rate in Nonspecific Endonuclease Business (2020-2025)

Figure 54. Yisheng Biotechnology (Shanghai) Co., Ltd. Revenue Growth Rate in Nonspecific Endonuclease Business (2020-2025)

Figure 55. GenScript Revenue Growth Rate in Nonspecific Endonuclease Business (2020-2025)

Figure 56. Shanghai Biyuntian Biotechnology Co., Ltd. Revenue Growth Rate in Nonspecific Endonuclease Business (2020-2025)

Figure 57. KACTUS Revenue Growth Rate in Nonspecific Endonuclease Business (2020-2025)

Figure 58. Shanghai Zhudian Biotechnology Co., Ltd. Revenue Growth Rate in Nonspecific Endonuclease Business (2020-2025)

Figure 59. ACROBiosystems Group Revenue Growth Rate in Nonspecific Endonuclease Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Nonspecific Endonuclease in 2031? zhanKai

The global market size of Nonspecific Endonuclease in 2031 was 650 Million USD.

What was the global market size of Nonspecific Endonuclease in 2025? shouQi

Which region is expected to have the highest market share? shouQi

What is the annual compound growth rate of the global Nonspecific Endonuclease market size from 2025 to 2031? shouQi

Which companies rank high in the global Nonspecific Endonuclease market? shouQi

Related Reports

Global Nonspecific Endonuclease Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Nonspecific Endonuclease market is projected to grow from US$ 398 million in 2025 to US$ 700 million by 2032, at a CAGR of 8.5% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 127
USD 4900.00
(Single User License)
Global Nonspecific Endonuclease Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Nonspecific Endonuclease market size was US$ 398 million in 2025 and is forecast to reach a readjusted size of US$ 700 million by 2032 with a CAGR of 8.5% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 76
USD 4250.00
(Single User License)
Nonspecific Endonuclease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Nonspecific Endonuclease was estimated to be worth US$ 398 million in 2025 and is projected to reach US$ 700 million, growing at a CAGR of 8.5% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 92
USD 3950.00
(Single User License)
Global Nonspecific Endonuclease Market Research Report 2026
The global Nonspecific Endonuclease market was valued at US$ 398 million in 2025 and is anticipated to reach US$ 700 million by 2032, at a CAGR of 8.5% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 105
USD 2900.00
(Single User License)
Global Nonspecific Endonuclease Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Nonspecific Endonuclease market is projected to grow from US$ 370 million in 2024 to US$ 650 million by 2031, at a CAGR of 8.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 126
USD 4900.00
(Single User License)
Global Nonspecific Endonuclease Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Nonspecific Endonuclease market size was US$ 370 million in 2024 and is forecast to a readjusted size of US$ 650 million by 2031 with a CAGR of 8.5% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 76
USD 4250.00
(Single User License)
Nonspecific Endonuclease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Nonspecific Endonuclease was estimated to be worth US$ 370 million in 2024 and is forecast to a readjusted size of US$ 650 million by 2031 with a CAGR of 8.5% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 91
USD 3950.00
(Single User License)
Nonspecific Endonuclease- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nonspecific Endonuclease, a genetically engineered enzyme from Serratia Marcescen. It can degrade all forms of DNA and RNA, including single-stranded, double-stranded, linear, circular, native and denatured nucleic acids, digesting them into 5-monophosphate oligonucleotides of 3-8 bases in length, and has no base recognition specificity.
Published Date: 2024-10-14
Pages: 92
USD 3950.00
(Single User License)
Global and United States Nonspecific Endonuclease Market Report & Forecast 2024-2030
Nonspecific Endonuclease, a genetically engineered enzyme from Serratia Marcescen. It can degrade all forms of DNA and RNA, including single-stranded, double-stranded, linear, circular, native and denatured nucleic acids, digesting them into 5-monophosphate oligonucleotides of 3-8 bases in length, and has no base recognition specificity.
Published Date: 2024-10-14
Pages: 93
USD 4350.00
(Single User License)
Global Nonspecific Endonuclease Market Research Report 2024
Nonspecific Endonuclease, a genetically engineered enzyme from Serratia Marcescen. It can degrade all forms of DNA and RNA, including single-stranded, double-stranded, linear, circular, native and denatured nucleic acids, digesting them into 5-monophosphate oligonucleotides of 3-8 bases in length, and has no base recognition specificity.
Published Date: 2024-10-14
Pages: 71
USD 2900.00
(Single User License)

Global Nonspecific Endonuclease Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Nonspecific Endonuclease market is projected to grow from US$ 398 million in 2025 to US$ 700 million by 2032, at a CAGR of 8.5% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 127
USD 4900.00 (Single User License)
Global Nonspecific Endonuclease Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Nonspecific Endonuclease market size was US$ 398 million in 2025 and is forecast to reach a readjusted size of US$ 700 million by 2032 with a CAGR of 8.5% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 76
USD 4250.00 (Single User License)
Nonspecific Endonuclease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Nonspecific Endonuclease was estimated to be worth US$ 398 million in 2025 and is projected to reach US$ 700 million, growing at a CAGR of 8.5% from 2026 to 2032.
Published: 2026-01-08
Pages: 92
USD 3950.00 (Single User License)
Global Nonspecific Endonuclease Market Research Report 2026
The global Nonspecific Endonuclease market was valued at US$ 398 million in 2025 and is anticipated to reach US$ 700 million by 2032, at a CAGR of 8.5% from 2026 to 2032.
Published: 2026-01-08
Pages: 105
USD 2900.00 (Single User License)
Global Nonspecific Endonuclease Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Nonspecific Endonuclease market is projected to grow from US$ 370 million in 2024 to US$ 650 million by 2031, at a CAGR of 8.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 126
USD 4900.00 (Single User License)
Global Nonspecific Endonuclease Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Nonspecific Endonuclease market size was US$ 370 million in 2024 and is forecast to a readjusted size of US$ 650 million by 2031 with a CAGR of 8.5% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 76
USD 4250.00 (Single User License)
Nonspecific Endonuclease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Nonspecific Endonuclease was estimated to be worth US$ 370 million in 2024 and is forecast to a readjusted size of US$ 650 million by 2031 with a CAGR of 8.5% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 91
USD 3950.00 (Single User License)
Nonspecific Endonuclease- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nonspecific Endonuclease, a genetically engineered enzyme from Serratia Marcescen. It can degrade all forms of DNA and RNA, including single-stranded, double-stranded, linear, circular, native and denatured nucleic acids, digesting them into 5-monophosphate oligonucleotides of 3-8 bases in length, and has no base recognition specificity.
Published: 2024-10-14
Pages: 92
USD 3950.00 (Single User License)
Global and United States Nonspecific Endonuclease Market Report & Forecast 2024-2030
Nonspecific Endonuclease, a genetically engineered enzyme from Serratia Marcescen. It can degrade all forms of DNA and RNA, including single-stranded, double-stranded, linear, circular, native and denatured nucleic acids, digesting them into 5-monophosphate oligonucleotides of 3-8 bases in length, and has no base recognition specificity.
Published: 2024-10-14
Pages: 93
USD 4350.00 (Single User License)
Global Nonspecific Endonuclease Market Research Report 2024
Nonspecific Endonuclease, a genetically engineered enzyme from Serratia Marcescen. It can degrade all forms of DNA and RNA, including single-stranded, double-stranded, linear, circular, native and denatured nucleic acids, digesting them into 5-monophosphate oligonucleotides of 3-8 bases in length, and has no base recognition specificity.
Published: 2024-10-14
Pages: 71
USD 2900.00 (Single User License)